| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692574 | European Urology | 2016 | 9 Pages |
Abstract
This study evaluated a novel urine-based assay that could be used as a noninvasive diagnostic aid for high-grade prostate cancer (PCa). When results of this assay are combined with traditional clinical risk factors, risk stratification for high-grade PCa and biopsy decision making are improved.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B. Cornel, Sander A. Jannink, Hans de Jong, Daphne Hessels, Frank P. Smit, Willem J.G. Melchers, Gisèle H.J.M. Leyten, Theo M. de Reijke, Henk Vergunst, Paul Kil,